The Good Food Institute (GFI) reports that private funding for cultivated meat has significantly declined, with companies raising only $139 million in 2024 (excluding a $55 million round from Prolific Machines), compared to $230 million in 2023 and $1.3 billion in 2021. GFI emphasizes that private capital alone is insufficient to fund first-of-a-kind facilities, urging companies to explore alternative funding sources like equipment leasing, strategic partnerships, and government programs. Despite progress in cost reduction and bioreactor optimization, the industry remains pre-revenue, with limited consumer adoption. Governments like China, India, and Singapore are investing in cultivated meat R&D, while others, like Italy, have attempted bans. GFI highlights the need for companies to de-risk operations by scaling production and lowering costs, but acknowledges challenges, as major players like UPSIDE Foods and GOOD Meat have delayed large-scale plans. The report underscores the sector’s reliance on blended finance and public support to overcome funding gaps and achieve commercialization.
Source: GFI: ‘No silver bullets will fill funding gaps in cultivated meat’